Theratechnologies Inc TH.TO reported a quarterly adjusted loss of 9 cents per share for the quarter ended May 31, lower than the same quarter last year, when the company reported EPS of 2 cents. The mean expectation of two analysts for the quarter was for a loss of one cent per share. Wall Street expected results to range from -4 cents to 1 cents per share.
Revenue fell 19.5% to $17.73 million from a year ago; analysts expected $17.55 million.
Theratechnologies Inc's reported EPS for the quarter was a loss of 9 cents.
The company reported a quarterly loss of $4.46 million.
Theratechnologies Inc shares had risen by 33.1% this quarter and gained 73.5% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 200% in the last three months.
In the last 30 days, there have been no negative revisions of earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
Wall Street's median 12-month price target for Theratechnologies Inc is $3.80, about 17.4% above its last closing price of $3.14
This summary was machine generated from LSEG data July 9 at 01:14 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
May. 31 2025 | -0.01 | -0.09 | Missed |
Feb. 28 2025 | 0.03 | 0.00 | Missed |
Nov. 30 2024 | 0.05 | -0.16 | Missed |
Aug. 31 2024 | 0.03 | 0.06 | Beat |